ICR in new collaboration to develop ‘next generation’ immunotherapy candidate 13 Dec 2021 Scientists at The Institute of Cancer Research, London, are working with the Cambridge-based immuno-oncology company Crescendo Biologics on its development of a potential ‘next generation’ immunotherapy. Find out more Show/Hide